Foundation Fighting Blindness
By Foundation Fighting Blindness
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by Foundation Fighting Blindness
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 4
Reviews: 0
Episodes: 257
Description
The Foundation Fighting Blindness is the driving force in the global development of treatments and cures for blinding diseases. To learn more, go to FightingBlindness.org.
| Episode | Date |
|---|---|
|
Atsena Therapeutics Advances to Pivotal Phase 3 Trial for X-Linked Retinoschisis
|
Apr 21, 2026 |
|
MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
|
Apr 16, 2026 |
|
Opus Genetics Secures $155 Million Financing to Accelerate Gene Therapy Pipeline
|
Apr 08, 2026 |
|
VeonGen Reports Promising Clinical Progress for Stargardt Disease Gene Therapy
|
Mar 26, 2026 |
|
Sumitomo Pharma Receives FDA Orphan Drug Designation for Retinitis Pigmentosa Treatment
|
Mar 24, 2026 |
|
Octant Bio Begins Clinical Testing Oral Treatment for Rhodopsin-Related Retinitis Pigmentosa
|
Mar 11, 2026 |
|
Opus Genetics Reports Promising Early Results from BEST1 Gene Therapy Trial
|
Mar 02, 2026 |
|
Eye on the Cure Podcast | Episode 100: BEST OF
|
Feb 27, 2026 |
|
SparingVision Completes Dosing in Gene-Agnostic Therapy Trial for Retinitis Pigmentosa (RP)
|
Feb 11, 2026 |
|
Blind & Beyond Radio Spotlight: Jason Menzo on Vision Research and Advocacy
|
Feb 08, 2026 |
|
Eye on the Cure Podcast | Episode 99: Dr. Prem Subramanian
|
Feb 06, 2026 |
|
Opus Genetics Receives Funding for Gene Therapy Clinical Trial for MERTK-Related RP
|
Jan 28, 2026 |
|
AAVantgarde Completes Enrollment in Retinal Gene Therapy Trial for Usher Syndrome Type 1B
|
Jan 16, 2026 |
|
SpliceBio Begins Dose-Expansion Phase of Clinical Trial for Stargardt Disease Protein Splicing Therapy
|
Jan 13, 2026 |
|
Eye on the Cure Podcast | Episode 98: Jonathan & Josh Steinberg
|
Jan 09, 2026 |
|
Eye on the Cure Podcast | Episode 97: Lindsey Rambo
|
Dec 19, 2025 |
|
Beacon Therapeutics Launches Clinical Trial for Bilateral Administration of XLRP Gene Therapy
|
Dec 18, 2025 |
|
Eye on the Cure Podcast | Episode 96: Dr. Deniz Dalkara
|
Dec 05, 2025 |
|
Belite Bio to Seek FDA Approval for its Stargardt Disease Drug
|
Dec 02, 2025 |
|
Opus Genetics Launches Gene Therapy Clinical Trial for Best Disease
|
Nov 14, 2025 |
|
Eye on the Cure Podcast | Episode 95: Greta Streimikyte
|
Nov 14, 2025 |
|
Eye on the Cure Podcast | Episode 94: Dr. Victoria Claire
|
Oct 31, 2025 |
|
SparingVision Launches Clinical Trial for Therapy to Re-Activate Dormant Cones in Advanced RP
|
Oct 28, 2025 |
|
Eye on the Cure Podcast | Episode 93: Sam Seavey
|
Oct 17, 2025 |
|
Sepul Bio’s LCA10 RNA Therapy Moves into Phase 3 Clinical Trial
|
Oct 02, 2025 |
|
Opus Reports Vision Improvements for Three Pediatric Patients in Phase 1/2 Clinical Trial for LCA5 Gene Therapy
|
Sep 30, 2025 |
|
Eye on the Cure Podcast | Episode 92: Lance Baldo, MD
|
Sep 26, 2025 |
|
Agnes Gund – Renowned Philanthropist, Social Justice Champion, and Art Patron – Passes Away
|
Sep 22, 2025 |
|
Nacuity’s Antioxidative Therapy NACA Performs Encouragingly in Phase 1/2 Clinical Trial
|
Sep 12, 2025 |
|
Eye on the Cure Podcast | Episode 91: Dr. George Magrath
|
Sep 05, 2025 |
|
Opus Genetics Receives FDA Clearance to Launch Clinical Trial for Best1 Gene Therapy
|
Aug 22, 2025 |
|
jCyte Launches New Phase 2 Clinical Trial for its Cell-Based RP Therapy
|
Aug 20, 2025 |
|
Eye on the Cure Podcast | Episode 90: Dr. Christina Ohnsman
|
Aug 08, 2025 |
|
Wet AMD Treatment Susvimo Preserves Vision for Five Years in Phase 3 Clinical Trial
|
Aug 06, 2025 |
|
Eye on the Cure Podcast | Episode 89: Dr. Christine Curcio
|
Jul 25, 2025 |
|
Ocugen Launches Phase 2/3 Clinical Trial for Stargardt Disease Gene-Modifier Therapy
|
Jul 21, 2025 |
|
Nanoscope Begins Rolling BLA Submission to FDA for Seeking Approval for its Optogenetic Therapy
|
Jul 14, 2025 |
|
Eye on the Cure Podcast | Episode 88: Richard Small
|
Jul 11, 2025 |
|
Atsena Gets FDA Nod to Expand XLRS Gene Therapy Clinical Trial to Include Pivotal Phase 3 Cohort
|
Jul 09, 2025 |
|
Eye on the Cure Podcast | Episode 87: Dr. Philip Beales
|
Jun 13, 2025 |
|
Eye on the Cure Podcast | Episode 86: Lenore von Krusenstiern, MD, PhD
|
May 23, 2025 |
|
J&J’s XLRP Gene Therapy Didn’t Meet Primary Endpoint in Phase 3 Clinical Trial
|
May 15, 2025 |
|
ARVO 2025 Highlight: PYC Reports Encouraging Phase 1/2 Clinical Trial Results for its RNA Therapy Targeting RP (PRPF31 Mutations)
|
May 13, 2025 |
|
ARVO 2025 Highlight: Atsena’s XLRS Gene Therapy Provides Vision and Structural Improvements in Phase 1/2 Clinical Trial
|
May 12, 2025 |
|
ARVO 2025 Highlight: Beacon Reports Encouraging Results for Second Eyes Dosed in Clinical Trial for XLRP Gene Therapy
|
May 09, 2025 |
|
Eye on the Cure Podcast | Episode 85: Cindy Elden
|
May 09, 2025 |
|
Eye on the Cure Podcast | Episode 84: Contact Congress
|
Apr 02, 2025 |
|
Eye on the Cure Podcast | Episode 83: Michel Michaelides
|
Mar 20, 2025 |
|
Luxa Reports Vision Improvements in Clinical Trial of its RPE Stem Cell Therapy for Dry AMD
|
Mar 11, 2025 |
|
Neurotech’s Encapsulated Cell Technology Receives FDA Approval for Treatment of MacTel
|
Mar 07, 2025 |
|
Eye on the Cure Podcast | Episode 82: Dr. Aaron Nagiel
|
Mar 05, 2025 |
|
Adverum Advancing Wet AMD Gene Therapy into Phase 3 Clinical Trials
|
Feb 28, 2025 |
|
LCA4 Gene Therapy Restores Meaningful Vision for Blind Children
|
Feb 24, 2025 |
|
Eye on the Cure Podcast | Episode 81: Ricky Enger
|
Feb 20, 2025 |
|
RD Fund Invests in Perceive Pharma for Development of Neuroprotective Therapies
|
Feb 18, 2025 |
|
Harriet Finkelstein, Foundation Angel, Passes Away
|
Feb 05, 2025 |
|
Eye on the Cure Podcast | Episode 80: Aniz Girach, MD
|
Jan 24, 2025 |
|
Atsena to Launch Part B of Phase 1/2 Clinical Trial for XLRS Gene Therapy
|
Jan 10, 2025 |
|
Eye on the Cure Podcast | Episode 79: Damon Lembi
|
Jan 06, 2025 |
|
ViGeneron Receives FDA Authorization to Launch Clinical Trial for mRNA Trans-splicing Gene Therapy for Stargardt Disease
|
Dec 20, 2024 |
|
Eye on the Cure Podcast | Episode 78: Dr. Sheldon Rowan
|
Dec 17, 2024 |
|
SpliceBio Receives FDA Clearance to Launch Clinical Trial for Stargardt Disease Protein Splicing Therapy
|
Dec 16, 2024 |
|
Sepul Bio Launches Phase 2b Clinical Trial for USH2A RNA Therapy
|
Dec 12, 2024 |
|
Eye on the Cure Podcast | Episode 77: Dr. Bob Bell
|
Dec 04, 2024 |
|
Atsena’s LCA1 Gene Therapy Licensed by Nippon Shinyaku for Markets in US and Japan
|
Nov 13, 2024 |
|
Eye on the Cure Podcast | Episode 76: The Lemay-Pelletier Family
|
Nov 12, 2024 |
|
BlueRock’s Photoreceptor Cell Therapy to Move into Clinical Trial
|
Oct 30, 2024 |
|
Kiora Receives Authorization for Phase 2 Clinical Trial of its Photoswitch for Advanced RP
|
Oct 29, 2024 |
|
Eye on the Cure Podcast | Episode 75: Sharon King
|
Oct 25, 2024 |
|
Opus Genetics, Ocuphire Merger to Boost Advancement of Several IRD Gene Therapies
|
Oct 23, 2024 |
|
#ShareYourVision | White Cane Day
|
Oct 15, 2024 |
|
Safety Clinical Trial Launched for Usher Syndrome 3 Drug
|
Oct 11, 2024 |
|
#ShareYourVision this Blindness Awareness Month | Jessie’s Story
|
Oct 11, 2024 |
|
Eye on the Cure Podcast | Episode 74: Dr. Kia Washington
|
Oct 11, 2024 |
|
#ShareYourVision | What do you want others to know about your unique vision?
|
Oct 11, 2024 |
|
Vision: A Memoir of Blindness and Justice — A New York Times Editor’s Pick
|
Sep 26, 2024 |
|
4DMT Planning Phase 3 Clinical Trial for Wet AMD Gene Therapy
|
Sep 23, 2024 |
|
Eye on the Cure Podcast | Episode 73: Dr. Zuhal Butuner
|
Sep 20, 2024 |
|
AAVantgarde Bio’s Dual-Vector USH1B Gene Therapy Moves into Phase 1/2 Clinical Trial
|
Sep 18, 2024 |
|
Nanoscope Planning Phase 3 Trial of its Optogenetic Therapy for People with Stargardt Disease
|
Sep 17, 2024 |
|
Eye on the Cure Podcast | Episode 72: Hannah Scanga
|
Aug 23, 2024 |
|
Eye on the Cure Podcast | Episode 71: Dr. Leonide Saad
|
Aug 09, 2024 |
|
Beacon Story | Para triathlete Deb Chucoski
|
Aug 06, 2024 |
|
AREDS Formula Reduces Risk of Visual Acuity Loss for People with Geographic Atrophy
|
Jul 30, 2024 |
|
Eye on the Cure Podcast | Episode 70: Karen Petrou
|
Jul 26, 2024 |
|
VISIONS 2024 | Karen Petrou "Vision for the Future"
|
Jul 19, 2024 |
|
VISIONS 2024 | Tribute, Awards and Closing
|
Jul 19, 2024 |
|
VISIONS 2024 | Eye Health and Nutrition
|
Jul 19, 2024 |
|
VISIONS 2024 | Gene Agnostic Therapeutic Approaches
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical Trials: What Should You Know?
|
Jul 19, 2024 |
|
VISIONS 2024 | Emerging Technologies
|
Jul 19, 2024 |
|
VISIONS 2024 | Genetic Therapies: Gene Therapy and Genome Editing
|
Jul 19, 2024 |
|
VISIONS 2024 | Stem Cells and Regenerative Medicine (session two)
|
Jul 19, 2024 |
|
VISIONS 2024 | Stem Cells and Regenerative Medicine (session one)
|
Jul 19, 2024 |
|
VISIONS 2024 | Optogenetics for Sight Restoration (session one)
|
Jul 19, 2024 |
|
VISIONS 2024 | Optogenetics for Sight Restoration (session two)
|
Jul 19, 2024 |
|
VISIONS 2024 | Inherited Retinal Disease Genetics: Testing and Registries
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical Trial Readiness
|
Jul 19, 2024 |
|
VISIONS 2024 | Navigating Air Travel—A Southwest Airlines Perspective
|
Jul 19, 2024 |
|
VISIONS 2024 | My Advocacy. My Choice.
|
Jul 19, 2024 |
|
VISIONS 2024 | Fireside Chat with Judge David Tatel
|
Jul 19, 2024 |
|
VISIONS 2024 | An In-Depth Process of Applying for a Guide Dog
|
Jul 19, 2024 |
|
VISIONS 2024 | Low Vision Aids and Devices
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical & Research Updates: Usher Syndrome
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical & Research Updates: Retinitis Pigmentosa
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical & Research Updates: Leber Congenital Amaurosis
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical & Research Updates: Stargardt Disease
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical & Research Updates: Macular Dystrophies
|
Jul 19, 2024 |
|
VISIONS 2024 | Clinical & Research Updates: Other Retinal Diseases (CHM, BCM, XLRS)
|
Jul 19, 2024 |
|
Eye on the Cure Podcast | Episode 69: Dr. Francois Paquet-Durand
|
Jul 12, 2024 |
|
Genentech to Re-Introduce Susvimo for Wet AMD
|
Jul 08, 2024 |
|
Eye on the Cure Podcast | Episode 68: Dr. Michael Telias
|
Jun 28, 2024 |
|
Eye on the Cure Podcast | Episode 67: Dr. Peter Campochiaro
|
Jun 07, 2024 |
|
Eye on the Cure Podcast | Episode 66: Peter Wallsten
|
May 24, 2024 |
|
ARVO 2024 Highlight: InGel’s Cell Therapy Shows Promise for Preserving Vision
|
May 22, 2024 |
|
ARVO 2024 Highlight: PYC Reports Initial Clinical Trial Results for its RNA Therapy Targeting RP
|
May 16, 2024 |
|
ARVO 2024 Highlight: New Gene Linked to RP in People with African Ancestry
|
May 14, 2024 |
|
ARVO 2024 Highlight: Positive Two-Year Results from PDE6B Gene Therapy Clinical Trial
|
May 10, 2024 |
|
Eye on the Cure Podcast | Episode 65: Matthew Whitaker
|
May 03, 2024 |
|
Atsena’s XLRS Gene Therapy Shows Efficacy in Phase 1/2 Clinical Trial
|
May 02, 2024 |
|
SalioGen Developing Novel Gene Insertion Therapy for Stargardt Disease
|
Apr 19, 2024 |
|
Eye on the Cure Podcast | Episode 64: Dr. Kapil Bharti
|
Apr 16, 2024 |
|
Phase 3 Clinical Trial of NAC Launched for RP Patients
|
Apr 12, 2024 |
|
ViGeneron Launches Clinical Trial of Gene Therapy for RP Caused by CNGA1 Mutations
|
Apr 11, 2024 |
|
Ocugen to Launch Phase 3 Clinical Trial of Modifier Gene Therapy for RP
|
Apr 08, 2024 |
|
Nanoscope Plans to Apply for FDA Approval for its Optogenetic Therapy
|
Mar 27, 2024 |
|
Opus Reports Vision Improvements for Patients in LCA5 Gene Therapy Clinical Trial
|
Mar 26, 2024 |
|
Eye on the Cure Podcast | Episode 63: Dr. Hema Ramkumar
|
Mar 08, 2024 |
|
Eye on the Cure Podcast | Episode 62: Dr. Peter Quinn
|
Feb 23, 2024 |
|
jCyte Announces Plans to Launch Phase 3 Clinical Trial of Cell Therapy for RP
|
Feb 21, 2024 |
|
Beacon Therapeutics Reports Encouraging Interim Results from Phase 2 Clinical Trial for XLRP
|
Feb 09, 2024 |
|
Eye on the Cure Podcast | Episode 61: Dr. Jose Sahel
|
Feb 02, 2024 |
|
Ascidian to Launch Clinical Trial for Stargardt Disease RNA Editing Therapy
|
Feb 01, 2024 |
|
Eye on the Cure Podcast | Episode 60: Justin Kauflin
|
Jan 19, 2024 |
|
Eye on the Cure Podcast | Episode 59: Dr. Robert MacLaren
|
Jan 05, 2024 |
|
Eye on the Cure Podcast | Episode 58: Jason Comander, MD, PhD
|
Dec 15, 2023 |
|
Théa Completes Acquisition of ProQR’s LCA10 and USH2A Treatment Programs
|
Dec 11, 2023 |
|
Eye on the Cure Podcast | Episode 57: James Rath
|
Dec 01, 2023 |
|
Eye on the Cure Podcast | Episode 56: Michael Voevodsky, MBA, CEO
|
Nov 10, 2023 |
|
Kiora Reports Vision Restoration in Phase 1/2 Clinical Trial for Photoswitch Therapy
|
Nov 08, 2023 |
|
New Report: Vitamin A Supplementation Provides No Vision Benefit to RP Patients
|
Nov 02, 2023 |
|
Eye on the Cure Podcast | Episode 55: Omar Mahroo, MB, PhD
|
Oct 13, 2023 |
|
Eye on the Cure Podcast | Episode 54: Rachelle Lin, OD, MS, FAAO
|
Sep 29, 2023 |
|
Ocugen Reports Updated Results for Clinical Trial of Modifier Gene Therapy
|
Sep 18, 2023 |
|
Eye on the Cure Podcast | Episode 53: David Birch, PhD
|
Sep 15, 2023 |
|
First Patient Dosed in LCA5 Gene Therapy Clinical Trial Launched by Opus Genetics
|
Sep 07, 2023 |
|
Eye on the Cure Podcast | Episode 52: Brendan Creemer
|
Sep 01, 2023 |
|
SparingVision Recruiting for Clinical Trial of Cone-Preserving Gene Therapy for RP
|
Aug 31, 2023 |
|
Atsena Doses First Patient in XLRS Gene Therapy Clinical Trial
|
Aug 28, 2023 |
|
Théa Acquires ProQR’s LCA10 and USH2A Treatment Programs, Plans to Continue Clinical Development
|
Aug 25, 2023 |
|
Eye on the Cure Podcast | Episode 51: Artur Cideciyan, PhD
|
Aug 18, 2023 |
|
Eye on the Cure Podcast | Episode 50: Rachel Huckfeldt, MD, PhD
|
Jul 21, 2023 |
|
PYC Doses First Patient in Clinical Trial of RNA Therapy for RP11 (PRPF31 Mutations)
|
Jul 12, 2023 |
|
Eye on the Cure Podcast | Episode 49: Alex Cohen, PhD
|
Jun 30, 2023 |
|
Eye on the Cure Podcast | Episode 48: Jami Kern, PhD
|
Jun 16, 2023 |
|
Eye on the Cure Podcast | Episode 47: Kari Branham
|
Jun 02, 2023 |
|
Coave Reports Encouraging Phase 1/2 Clinical Trial Results for PDE6B Gene Therapy
|
Jun 01, 2023 |
|
Eye on the Cure Podcast | Episode 46: Aaron Osborne, MD
|
May 19, 2023 |
|
Atsena Receives FDA Authorization to Launch a Gene Therapy Clinical Trial for XLRS
|
May 02, 2023 |
|
Eric Pierce Receives Proctor Medal for Outstanding Achievements in Retinal Research
|
May 01, 2023 |
|
News | Budd Tucker Honored with Award for Advancements in Retinal Therapy Development
|
Apr 28, 2023 |
|
Eye on the Cure Podcast | Episode 45: Henry Klassen, MD, PhD
|
Apr 28, 2023 |
|
News | Bionic Sight Reports Vision Improvements for RP Patients in its Emerging Optogenetic Therapy
|
Apr 20, 2023 |
|
Eye on the Cure Podcast | Episode 44: Jason Taylor
|
Apr 14, 2023 |
|
Eye on the Cure Podcast | Episode 43: Marinna Madrid, PhD
|
Mar 31, 2023 |
|
News | Vision Improvements Reported for RP Patients in Phase 2B Nanoscope Clinical Trial
|
Mar 30, 2023 |
|
Eye on the Cure Podcast | Episode 42: Paul Bresge
|
Mar 10, 2023 |
|
Eye on the Cure Podcast | Episode 41: Dean Bok, PhD
|
Feb 24, 2023 |
|
Eye on the Cure Podcast | Episode 40: Rebecca Alexander
|
Feb 10, 2023 |
|
Eye on the Cure Podcast | Episode 39: Paul Bernstein, MD, PhD
|
Jan 20, 2023 |
|
Eye on the Cure Podcast | Episode 38: Ben Shaberman
|
Jan 06, 2023 |
|
Eye on the Cure Podcast | Episode 37: Rando Allikmets, PhD
|
Dec 16, 2022 |
|
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
|
Dec 02, 2022 |
|
News | Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
|
Dec 02, 2022 |
|
Eye on the Cure Podcast | Episode 36: Sue Bramhall
|
Dec 02, 2022 |
|
Eye on the Cure Podcast | Episode 35: Kenji Fujita, MD
|
Nov 18, 2022 |
|
Editas Reports Results for 14 Participants in its Phase 1/2 CRISPR/Cas9 Clinical Trial for LCA10
|
Nov 18, 2022 |
|
Eye on the Cure Podcast | Episode 34: LambdaVision
|
Nov 04, 2022 |
|
#ShareYourVision | Advice for the Newly Diagnosed
|
Oct 30, 2022 |
|
#ShareYourVision | How to Assist a Visually Impaired Person
|
Oct 28, 2022 |
|
#ShareYourVision Story: Monica Pruitt
|
Oct 27, 2022 |
|
#ShareYourVision Story: Dan Day
|
Oct 26, 2022 |
|
#ShareYourVision | Strange Interactions
|
Oct 26, 2022 |
|
#ShareYourVision | Blindness Is a Spectrum
|
Oct 24, 2022 |
|
#ShareYourVision | The Role Foundation Fighting Blindness Has In Their Lives
|
Oct 20, 2022 |
|
#ShareYourVision Story: Jake Ellis
|
Oct 18, 2022 |
|
#ShareYourVision Story: Chad Bouton
|
Oct 16, 2022 |
|
#ShareYourVision | Questions We're Tired of Being Asked
|
Oct 15, 2022 |
|
#ShareYourVision Story: Raquel
|
Oct 14, 2022 |
|
#ShareYourVision | Creative Hacks for Living with Vision Loss
|
Oct 13, 2022 |
|
#ShareYourVision Story: JJ Martinez
|
Oct 12, 2022 |
|
#ShareYourVision | The Positives & Negatives of Going Blind
|
Oct 12, 2022 |
|
#ShareYourVision Story: Brett Knight
|
Oct 11, 2022 |
|
#ShareYourVision Story: Martha Steel
|
Oct 10, 2022 |
|
#ShareYourVision | First Time Meeting Another Blind Person
|
Oct 10, 2022 |
|
#ShareYourVision | Why It's Important to Share Your Vision Story
|
Oct 05, 2022 |
|
Eye on the Cure Podcast | Episode 33: Jacque Duncan, MD
|
Oct 04, 2022 |
|
News | Atsena’s LCA-GUCY2D Gene Therapy Improves Vision in Phase 1/2 Clinical Trial
|
Oct 03, 2022 |
|
#ShareYourVision | Blindness Is...
|
Oct 03, 2022 |
|
#ShareYourVision Story: Michelle Glaze
|
Sep 29, 2022 |
|
Eye on the Cure Podcast | Episode 32: Dr. Sandy Greenberg
|
Sep 23, 2022 |
|
Eye on the Cure Podcast | Episode 31: Jean Bousquet
|
Sep 09, 2022 |
|
News | Belite Bio Launching Phase 3 Clinical Trial for Stargardt Disease Drug
|
Aug 29, 2022 |
|
Eye on the Cure Podcast | Episode 30: Steven McCoy
|
Aug 19, 2022 |
|
Eye on the Cure Podcast | Episode 29: David Gamm, MD, PhD
|
Aug 05, 2022 |
|
Eye on the Cure Podcast | Episode 28: Brian Strem, PhD
|
Jul 22, 2022 |
|
Eye on the Cure Podcast | Episode 27: Jeff Stern and Sally Temple
|
Jul 08, 2022 |
|
VISIONS 2022 | Your Journey Toward Independent Mobility
|
Jul 07, 2022 |
|
VISIONS 2022 | Clinical & Research Updates: Age-Related Macular Degeneration (AMD)
|
Jul 07, 2022 |
|
VISIONS 2022 | Clinical & Research Updates: Rare IRDs
|
Jul 07, 2022 |
|
VISIONS 2022 | Clinical & Research Updates: Retinitis Pigmentosa (RP)
|
Jul 07, 2022 |
|
VISIONS 2022 | Clinical & Research Updates: Usher Syndrome
|
Jul 07, 2022 |
|
VISIONS 2022 | Living Life To the Fullest: How Low Vision Occupational Therapy Can Help
|
Jul 07, 2022 |
|
VISIONS 2022 | Blind Athletes Breaking Barriers
|
Jul 07, 2022 |
|
VISIONS 2022 | RD Fund Biotech Overview
|
Jul 07, 2022 |
|
VISIONS 2022 | Stem Cells in Retinal Disease
|
Jul 07, 2022 |
|
VISIONS 2022 | Gene & Genetic Technologies
|
Jul 07, 2022 |
|
Eye on the Cure Podcast | Episode 26: Rachel Wong, PhD
|
Jun 24, 2022 |
|
Eye on the Cure Podcast | Episode 25: Frank Bruni
|
Jun 10, 2022 |
|
Eye on the Cure Podcast | Episode 24: Ash Jayagopal, PhD
|
May 06, 2022 |
|
News | Encouraging Clinical Trial Results for Alkeus’ Stargardt Disease Treatment
|
May 02, 2022 |
|
Eye on the Cure Podcast | Episode 23: John Flannery, PhD
|
Apr 22, 2022 |
|
Eye on the Cure Podcast | Episode 22: Judge David Tatel
|
Apr 08, 2022 |
|
Eye on the Cure Podcast | Episode 21: Katriona Taylor
|
Mar 25, 2022 |
|
Eye on the Cure Podcast | Episode 20: Dr. Nancy Holekamp
|
Mar 11, 2022 |
|
Eye on the Cure Podcast | Episode 19: Nieraj Jain, MD
|
Feb 25, 2022 |
|
Eye on the Cure Podcast | Episode 18: Michael Stone
|
Feb 11, 2022 |
|
Eye on the Cure Podcast | Episode 17: Tom Reh, PhD
|
Jan 28, 2022 |
|
Eye on the Cure Podcast | Episode 16: Actor Ben Mehl
|
Jan 14, 2022 |
|
News | Ocugen to Launch Clinical Trial for Cross-Cutting RP Gene Therapy
|
Dec 13, 2021 |
|
Eye on the Cure Podcast | Episode 15: Gordon Gund
|
Dec 10, 2021 |
|
Eye on the Cure Podcast | Episode 14: Michael Kalberer
|
Nov 19, 2021 |
|
Eye on the Cure Podcast | Episode 13: Dave Knop, PhD
|
Nov 05, 2021 |
|
News | FDA Approves Genentech’s Susvimo for Treating Wet AMD
|
Oct 25, 2021 |
|
Eye on the Cure Podcast | Episode 12: Michael Young, PhD
|
Oct 22, 2021 |
|
Eye on the Cure Podcast | Episode 11: Silvia Sorensen, PhD
|
Oct 08, 2021 |
|
Eye on the Cure Podcast | Episode 10: Dr. Naveed Shams, ProQR
|
Sep 24, 2021 |
|
Eye on the Cure Podcast | Episode 9: Stephen Daiger, PhD
|
Sep 10, 2021 |
|
Eye on the Cure Podcast | Episode 8: Ben Shaberman, Genetic Testing
|
Aug 20, 2021 |
|
Eye on the Cure Podcast | Episode 7: Bonnie Swenor, MPH, PhD
|
Aug 13, 2021 |
|
Eye on the Cure Podcast | Episode 6: Drs. Troyk and Lane
|
Jul 30, 2021 |
|
Eye on the Cure Podcast | Episode 5: Morten Bonde
|
Jul 16, 2021 |
|
Eye on the Cure Podcast | Episode 4: Jill Dolgin, AGTC
|
Jul 02, 2021 |
|
News | AGTC Reports Encouraging Results from Phase 1/2 Gene Therapy Clinical Trial for Achromatopsia
|
Jun 25, 2021 |
|
Eye on the Cure Podcast | Episode 3: Dr. Daniel Chung
|
Jun 18, 2021 |
|
Eye on the Cure Podcast | Episode 2: Sheila Nirenberg, PhD
|
May 28, 2021 |
|
Eye on the Cure Podcast | Episode 1: Welcome
|
May 14, 2021 |
|
News | AGTC Continues to Report Encouraging Data from its Phase 1/2 XLRP Gene Therapy Clinical Trial
|
May 10, 2021 |
|
News | Microperimetry Emerging as a Valuable Tool in Measuring Treatment Efficacy in Clinical Trials
|
May 10, 2021 |
|
News | ARVO 2021 Highlight: CRISPR/Cas9 Therapy Emerging for Dominant RP Caused by RP1 Mutations
|
May 05, 2021 |
|
News | ARVO 2021 Highlight: Update on Clinical Trial of jCyte’s Cellular Therapy for RP
|
May 03, 2021 |
|
News | SparingVision to Acquire Therapy for Resurrecting Dormant Cones for Vision Restoration
|
Apr 26, 2021 |
|
Beacon Story | Ellen Gould | My Big Break
|
Feb 21, 2021 |
|
Beacon Story | Tracy Minish | Five Generations
|
Feb 20, 2021 |
|
Beacon Story | Charlie Kramer | Cane Signals
|
Feb 20, 2021 |
|
Beacon Story | Dr. Shannon Boye | It's Possible
|
Feb 19, 2021 |
|
Beacon Story | Carolyn Covington | Life After Blindness
|
Feb 18, 2021 |